Grand Junction, CO10 Active Studies

Lung Cancer Clinical Trials in Grand Junction, CO

Find 10 actively recruiting lung cancer clinical trials in Grand Junction, CO. Connect with local research sites and explore new treatment options.

10
Active Trials
8
Sponsors
6,792
Enrolling

Recruiting Lung Cancer Studies in Grand Junction

NCT07168993Recruiting

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Evaluate FlowPath Lung Diagnostic Test of Sputum Samples to Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, \>6 to \<30 mm in Diameter, Determined by LDCT....

Grand Junction, CONA2,063 participantsbioAffinity Technologies Inc.
View Study Details
NCT06561386Recruiting

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squa...

Grand Junction, COPHASE31,000 participantsBristol-Myers Squibb
View Study Details
NCT06422143Recruiting

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed by pembrolizumab with or without maintenance sacituzumab tirumotecan (sac-TMT; M...

Grand Junction, COPHASE3851 participantsMerck Sharp & Dohme LLC
View Study Details
NCT06758401Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

The purpose of the study is to compare how the new combination treatment (Sigvotatug Vedotin plus pembrolizumab) works compared to pembrolizumab alone in patients with non-small cell lung cancer (NSCL...

Grand Junction, COPHASE3714 participantsPfizer
View Study Details
NCT06170788Recruiting

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival (OS). The primary hypothesis is that the co...

Grand Junction, COPHASE3614 participantsMerck Sharp & Dohme LLC
View Study Details
NCT07291037Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

TROPION-Lung17 will measure the efficacy and safety of datopotamab deruxtecan (Dato-DXd) compared with docetaxel in patients with trophoblast cell surface protein 2 (TROP2) positive advanced or metast...

Grand Junction, COPHASE3400 participantsAstraZeneca
View Study Details
NCT07005128Recruiting

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

The main objective of the study is to compare the efficacy of tarlatamab in combination with durvalumab, carboplatin and etoposide to the combination of durvalumab, carboplatin and etoposide on prolon...

Grand Junction, COPHASE3330 participantsAmgen
View Study Details
NCT06686771Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

This study is being done to answer the following question: Can the chance of lung cancer growing or spreading be lowered by adding targeted radiotherapy to the usual combination of drugs? This study ...

Grand Junction, COPHASE3320 participantsCanadian Cancer Trials Group
View Study Details
NCT04916990Recruiting

Improving Care for Rural Patients With Solid Tumors

This study will assess if the CARES (Cancer Advocacy, Resources, Education and Support) intervention improves time to start of treatment after diagnosis and time to treatment completion for solid tumo...

Grand Junction, CONA320 participantsUniversity of Colorado, Denver
View Study Details
NCT06448754Recruiting

Volrustomig Priming Regimens Exploratory Phase II Platform Study

Purpose of this study is to assess the safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of volrustomig in combination with other anticancer drugs in participants with spe...

Grand Junction, COPHASE2180 participantsAstraZeneca
View Study Details

About Lung Cancer Clinical Trials in Grand Junction

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 10 lung cancer clinical trials recruiting participants in Grand Junction, CO. These studies are seeking a combined 6,792 participants. Research is being sponsored by bioAffinity Technologies Inc., Bristol-Myers Squibb, Merck Sharp & Dohme LLC and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Grand Junction — FAQ

Are there lung cancer clinical trials in Grand Junction?

Yes, there are 10 lung cancer clinical trials currently recruiting in Grand Junction, CO. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Grand Junction?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Grand Junction research site will contact you about next steps.

Are clinical trials in Grand Junction free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Grand Junction studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 10 active trials in Grand Junction are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated July 22, 2026 from ClinicalTrials.gov